跳至主要内容
临床试验/CTRI/2025/08/092664
CTRI/2025/08/092664尚未招募Phase 3 4

Effectiveness of individualized homoeopathic treatment on quality of life and clinical symptoms in eczema

Post graduate research funded by college1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2025年8月20日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
28
试验地点
1
主要终点
To assess the quality-of-life improvement in patients with eczema, as measured by the dermatology life quality index (DLQI), with homoeopathic medications.

研究概览

简要总结

Eczema is a skin condition that extends beyond physical symptoms, causing emotional distress, social stigma, and impacts on daily life, including career and personal relationships. The prevalence of Eczema ranged from 0.98% to 9.2% in studies including paediatric and adult patients. The cost of medications was reported to be the major contributor to the economic burden associated with Eczema. This prospective study aims to evaluate the effectiveness of individualized homoeopathic treatment on the quality of life and symptom severity in patients diagnosed with Eczema. A total of 28 patients, aged between 16 to 65 years and of both sexes, will be enrolled from the Outpatient Department (OPD), Inpatient Department (IPD), and affiliated rural health centres of Sarada Krishna Homoeopathic Medical College. Each patient will undergo a thorough case-taking process, and homoeopathic medicines will be prescribed based on the totality of symptoms. The primary outcome measures for the study include the Dermatology Life Quality Index (DLQI), a validated tool to assess the impact of skin diseases on patients’ daily lives, and the Eczema Area Severity Index(EASI), which is employed to objectively measure the severity of eczema symptoms. The pre-assessment is conducted during the initial visit, followed by regular follow-up every 14 days. The cases are being observed over a period of 6 months. Post-assessments will be done at the end of 3 months and again at the end of 6 months using the DLQI and EASI. All relevant clinical data and patient responses will be systematically documented throughout the study. This study aims to provide observational evidence on the role of individualised homoeopathic treatment in managing eczema and improving patients’ quality of life, thereby contributing to integrative dermatological care. The outcomes may support further research into the potential benefits of homoeopathy in chronic dermatological conditions.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age group between 16 years to 65 years.
  • Both sexes.
  • Patients of all socioeconomic types.

排除标准

  • Pregnant and Lactating women.
  • Patients with serious systemic illness.

结局指标

主要结局

To assess the quality-of-life improvement in patients with eczema, as measured by the dermatology life quality index (DLQI), with homoeopathic medications.

时间窗: 6 months

次要结局

  • To assess the reduction in severity of symptoms of eczema with homoeopathic medicines.(6 months)

研究者

发起方
Post graduate research funded by college
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr ANGELA B WILLIAMS

Sarada krishna homoeopathic medical college

研究点 (1)

Loading locations...

相似试验